BMI1 and glioblastoma: Clinically, miR‐128 expression correlates with improved overall survival in patients with GBM, and upregulation of miR‐128 decreases H3K27me3 histone methylation and increases p21/Cip1 levels, consistent with Bmi‐1 downregulation [71, 74].